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Abstract
Biological electron transfer reactions between metal cofactors are critical to many essential 
processes within the cell. Duplex DNA is, moreover, capable of mediating the transport of charge 
through its π-stacked nitrogenous bases. Increasingly, [4Fe4S] clusters, generally redox-active 
cofactors, have been found to be associated with enzymes involved in DNA processing. DNA-
binding enzymes containing [4Fe4S] clusters can thus utilize DNA charge transport (DNA CT) for 
redox signaling to coordinate reactions over long molecular distances. In particular, DNA CT 
signaling may represent the first step in the search for DNA lesions by proteins containing [4Fe4S] 
clusters that are involved in DNA repair. Here we describe research carried out to examine the 
chemical characteristics and biological consequences of DNA CT. We are finding that DNA CT 
among metalloproteins represents powerful chemistry for redox signaling at long range within the 
cell.
Graphical Abstract
1. Introduction
Electron transfer reactions are integral components of fundamental processes in biology. 
These reactions often occur between two proteins that coordinate metals[1] such as Fe, Mn, 
Zn, or Cu. Metal centers in proteins can facilitate the single electron redox reactions central 
to biological processes such as respiration[2] and photosynthesis[3]. The mitochondrial 
respiratory chain, for example, involves several electron transfer processes, mediated by the 
metal cofactors in large, multiprotein complexes.[4–12] Several iron-sulfur centers and heme 
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proteins mediate redox activity essential to driving the oxidative phosphorylation that 
aerobic organisms use to generate energy.[2,4–6]
These redox reactions and others occur between donors and acceptors that are in relative 
proximity to one another; the electron transfer steps driving respiration occur within a single 
complex or between adjacent respiratory chain complexes in the mitochondrial 
membrane.[2,4–12] As established in beautiful studies by Gray and coworkers, biological 
electron transfer reactions can span over distances exceeding the single-step tunneling limit 
of ~20Å;[4] extensive studies with Ru- and Re-modified proteins[4,13–16] directly 
demonstrate intraprotein charge transfer over distances greater than this limit. Here, 
metalloproteins coordinate these reactions in multiple steps, using multistep electron 
tunneling, or electron hopping, through the insulating protein matrix. A strategically 
positioned aromatic residue such as tyrosine or tryptophan, with a relatively low ionization 
potential,[17,18] can increase the rate of electron transfer through a protein matrix.[14,16] A 
mutant azurin containing a covalent [Re(CO)3(dmp)]+ (dmp= 4,7-dimethyl-1,10-
phenantroline) photooxidant coordinated by His 124 and a Trp residue engineered 
approximately halfway between the Cu (I) electron donor and photoexcited Re (II) acceptor, 
for example, has been demonstrated to transfer charge over a ~20Å distance approximately 
100 times faster than the predicted time for the single-step tunneling reaction.[16] Nature can 
thus design proteins optimized for efficient redox chemistry within a macromolecule or a 
complex, but can biological electron donors and acceptors also couple with one another from 
still longer distances, to coordinate a genome-wide process such as DNA repair?
Here we focus on electron transfer reactions across DNA, another important biological 
macromolecule. We describe the extensive characterization of this chemistry in many 
laboratories and how study of long-range electron transfer through DNA led us also to 
examine the redox chemistry of DNA processing enzymes that coordinate iron cofactors. 
The ubiquity of [4Fe4S] clusters being associated with enzymes involved in DNA 
processing has led us to consider roles where electron transfer reactions through DNA might 
be beneficially applied. This review is not exhaustive, but it is intended to illustrate the 
unique features of DNA charge transport chemistry and how these features may be utilized 
within the cell.
2. Fundamentals of DNA Charge Transport
Electron transfer through protein matrices occurs on the microsecond timescale,[4] mediated 
by σ bonds and hydrogen bonds. Electron transfer reactions occur through duplex DNA, 
however, at a significantly faster rate.[19–27] DNA-mediated charge transport (DNA CT) is 
mediated by the π-stacking interactions of the nitrogenous bases at the center of the DNA 
helix and occurs on the picosecond timescale.[27] The aromatic bases, stacked in 3.4 Å 
layers, contain overlapping π orbitals in a structure closely resembling that of stacked 
graphene sheets (Figure 1). After observing this similarity in structure between DNA and 
graphite in the dry, solid state, Eley and Spivey[28] along with others predicted that the DNA 
helix, based upon its chemical structure, would conduct charge. Our laboratory has observed 
that DNA-mediated charge transport occurs over long range[22,26] and is shallowly 
dependent on molecular distance traveled.[23,26,29–31] DNA CT indeed occurs through the 
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nitrogenous base pairs, whose overlapping π orbitals provide a pathway for charge to travel 
down the helical base pair stack.[19–31] This property is additionally exquisitely sensitive to 
perturbations in the stacking interactions of the bases, such as those that occur with base-pair 
mismatches and lesions.[23,29–31]
Studies of DNA CT by our laboratory and others have prompted several proposals about the 
mechanism through which CT occurs under aqueous, biologically relevant 
conditions. [23,25–39] Superexchange between DNA bases was proposed but cannot explain 
the long molecular distances over which DNA-mediated CT is observed.[32–35,40] Localized 
hopping has also been suggested to mediate DNA CT, as charge can migrate along DNA 
through superexchange between neighboring guanine bases in the sequence.[41] This model, 
however, cannot fully explain the weak distance dependence of DNA CT consistently 
demonstrated[42–44] or the attenuation of DNA CT in the presence of base-pair 
mismatches.[23,26,29–31] Delocalization of charge likely occurs through transient interactions 
influenced by dynamic changes in the duplex DNA structure in solution[27,38,45] and perhaps 
also formation of polarons in the vicinity of charge moving through DNA.[36,37,39] Long-
range, shallowly distance-dependent DNA CT thus depends on several factors and cannot be 
adequately explained by a single mechanism. Charge migration through DNA likely occurs 
through a variety of pathways, with some delocalization over DNA domains gated by the 
DNA conformational dynamics.[38,46]
Though these studies have demonstrated a variety of mechanistic processes at work during 
DNA CT, they also consistently demonstrate its key properties under all conditions assayed. 
DNA charge transport occurs over long molecular distances[29–31,38,46–48] and exhibits a 
shallow dependence on distance traveled.[29–31,40,46–49] Charge transfer through DNA 
furthermore requires coupling of electron donors and acceptors into the π-stack and is 
attenuated in the presence of perturbations in the base stacking interactions, such as base-
pair mismatches,[23,29–31] bulky lesions in the duplex sequence,[50] or severe structural 
distortion of the helical stacking.[51,52] These fundamental characteristics all suggest that 
Nature may harness DNA CT during the search for and subsequent repair of DNA damage 
sites, which attenuate charge transport.
3. DNA-binding Proteins contain [4Fe4S] Clusters
Duplex DNA with well-stacked bases is thus a strikingly effective mediator of charge 
transport, but what proteins serve as the electron donors and acceptors? In order to utilize 
DNA CT for long-range redox reactions, electron donors and acceptors must both possess a 
metal center capable of one-electron transfer reactions and bind duplex DNA such that their 
redox centers are coupled into the π-stacked bases. Cunningham and coworkers initially 
discovered[53] in 1989 that the base excision repair (BER) glycosylase Endonuclease III 
(EndoIII) in E. coli, which repairs oxidized pyrimidine bases[54] in genomic DNA, contains 
a [4Fe4S] cluster cofactor. Several other DNA repair proteins including BER glycosylase 
MutY (E. coli),[55] family 4 Uracil-DNA glycosylase from thermophiles (UDG),[56] 
Nucleotide excision repair helicase XPD (S. acidocaldarius) (SaXPD),[57] and R-loop 
maturation helicase DinG (E. coli)[58] have since been discovered to contain [4Fe4S] 
clusters. The transcription factor SoxR, which binds DNA and activates transcription of soxS 
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genes to defend the cell during oxidative stress, has additionally been shown to contain a 
[2Fe2S] cluster cofactor.[59] Remarkably eukaryotic DNA polymerases and DNA primase 
were also recently shown to contain[4Fe4S] centers.[60,61]
Iron-sulfur cofactors, such as the rhomboid [2Fe2S] cluster and cubane [4Fe4S] cluster 
(Figure 2), are often agents of redox chemistry in biology, with a tunable range of potentials 
from 300mV to below −500mV vs. NHE.[62] These species likely arose during prebiotic 
conditions on Earth, when an abundance of ferrous iron and sulfide would have been present 
in the atmosphere.[63] These cofactors are generally coordinated by conserved cysteine 
motifs, and require a large group of proteins to assemble and load the clusters into their 
recipient proteins.[1,64,65] Incorporation of an iron-sulfur cofactor into a protein is a complex 
and metabolically expensive task for cellular machinery, requiring biogenesis and assembly 
proteins, chaperone proteins for transport, and in the case of eukaryotes, a targeting complex 
comprising of three proteins (CIA1, CIA2, and MMS19)[64–66] to load the cofactor into its 
recipient protein.
The general process for iron-sulfur biogenesis and loading is summarized in Figure 2. In 
bacteria, the ISC assembly machinery is generally responsible for cofactor generation, 
though the NIF system has been identified as part of the maturation pathway for the iron-
sulfur containing enzyme nitrogenase and the SUF assembly system is implicated in 
biogenesis during oxidative stress.[1] In eukaryotes, the ISC assembly machinery and 
mitochondrial ISC export system are necessary for biogenesis of the cofactor[67] and the 
cytosolic iron-sulfur assembly (CIA) machinery is required for cluster maturation.[68,69] 
Inorganic sulfur is acquired from a cysteine desulfurase (IscS) in bacteria or exported from 
the mitochondria by Atm1,[67,70] then bound by a cysteine desulfurase (NFS1) in 
eukaryotes. Cysteine desulfurase activity converts cysteine to alanine, generating a 
persulfide which is then transported directly or indirectly to scaffold proteins (IscU in 
bacteria, ISU in eukaryotes) for cluster assembly. Ferrous iron is donated by a protein 
source, and electron transfer occurs to reduce S0 to S2− present in iron-sulfur clusters. After 
the de novo biosynthesis of a labile cluster coordinated by scaffold protein cysteine residues, 
the cluster-containing scaffold associates with chaperone proteins (HscA/HscB in bacteria, 
HSC20/HSPA9 in eukaryotes). ATP hydrolysis likely drives a conformational change in 
order to keep the labile cluster shielded during delivery to the recipient protein,[1,64] and 
direct or indirect transfer of the cofactor to the recipient protein occurs.
Creation and incorporation of iron-sulfur clusters into proteins is thus a metabolically 
expensive task requiring the engagement of several protein systems. Placing an iron-
containing cofactor in a DNA-binding protein could additionally place the bound nucleic 
acid at risk of damage. A labile ferrous iron from the cofactor could react with hydrogen 
peroxide in the cellular environment; this Fenton chemistry creates reactive oxygen species 
(Figure 2) which could damage nearby DNA bases. Why then does Nature spend the 
requisite energy incorporating a redox-active inorganic cofactor into a DNA-processing 
enzyme?
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4. Platforms to Study DNA CT
The development of new methods was necessary to test whether DNA conducted charge in 
solution at ambient temperatures. Certainly, assessing potential biological roles for DNA CT 
chemistry requires experiments to be performed in aqueous solution using physiologically 
relevant conditions. Key properties of DNA charge transport have now been characterized 
extensively, through the development of several robust and versatile 
platforms.[19–27, 50–52–71–81] DNA CT has been studied in the excited state and the ground 
state, as well as using single- molecule assays. Across all of the platforms developed, 
consistent features of DNA CT are observed: (i) charge transport through duplex DNA is 
dependent on the coupling of redox donors and acceptors to the π-stacked bases; (ii) DNA 
CT can occur over long molecular distances with shallow distance dependence; and (iii) 
DNA CT is attenuated in the presence of even minor perturbations in π-stacking interactions 
between the bases.
Our laboratory initially assayed the charge transport properties of DNA using photophysical 
studies, employing DNA-intercalating redox donors and acceptors. We covalently appended 
metal complexes such as [Ru(phen)2dppz]2+ (phen= 1,10 phenanthroline, dppz = 
dipyrido[3,2-a:2′,3′-c]-phenazine) and [Rh(phi)2(phen)]3+ (phi = 9,10-phenanthrenequinone 
diamine) to a short, 15-bp oligonucleotide.[19] These metal complexes intercalate into the 
duplex DNA bases and upon irradiation, [Ru(phen)2dppz]2+ acts as a luminescence donor, 
which is quenched through an intra-duplex mechanism by the [Rh(phi)2(phen)]3+ acceptor. 
(Figure 3) When an oligonucleotide modified with the [Ru(phen)2dppz]2+ donor and 
[Ru(phen)2(phen′)]2+ (phen′= 5-amido-glutaric-acid-1,10-phenanthroline), a poor DNA 
intercalator, is irradiated, luminescence is no longer quenched, suggesting a mechanism 
dependent on intercalation, which is required for coupling of the donor and acceptor into the 
DNA duplex.
To investigate further the mechanism of charge transport through DNA bases, we assayed 
luminescence quenching of fluorescent base analogues 2-aminopurine (A2) and 1,N6-
ethenoadenine (Aε) by guanine (G) or deazaguanine (Z)[25] which possess low enough redox 
potentials to act as acceptors.[82] This assembly allowed for investigation of DNA CT 
without potential constraining effects of covalent intercalating metal complex donors and 
acceptors on the DNA helix structure. A long-range, shallowly distance-dependent 
mechanism of quenching for A2, which couples well into the DNA π stack, was observed. 
This mechanism was not observed, however, for the bulkier Aε analogue, which is less 
capable of π-stacking and thus less effective in coupling into duplex DNA.[25] Fluorescence 
quenching of a DNA-intercalated ethidium donor by a [Rh(phi)2(bpy)]3+ acceptor through a 
17-bp DNA duplex, moreover, is fivefold less efficient in the presence of a single CA base 
pair mismatch, relative to a well-matched duplex.[23] These results together suggest that 
well-stacked DNA bases are essential for charge transfer through DNA; perturbing the π-
stacking interactions severely attenuates DNA CT.
Using DNA-intercalating photooxidants, we have also observed DNA charge transport or 
DNA damage generated at a distance. An intercalating oxidant such as [Rh(phi)2(bpy′)]3+ 
(bpy′= 4-butyric acid, 4′-methylbipyridine) can be tethered to one end of a 63-bp duplex 
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DNA substrate and photoexcited, oxidizing low-potential guanine bases at the 5′-end of a 
5′-GG′-3′ doublet sequence.[26] (Figure 3) Photolysis leads to the oxidation product 7,8-
dihydro-8-oxo-2′-deoxyguanosine (8-oxo-G) to form in a DNA-mediated manner, observed 
up to 200 Å from the site of intercalation. These reactions also have been demonstrated to 
occur on the picosecond timescale;[27] charge can move 10 times the single-step tunneling 
distance through protein in a miniscule fraction of the time!
Additional platforms have been used to study DNA CT in the excited state, elucidating the 
mechanisms at play during a DNA-mediated charge transport event. Injection of charge 
through photoexcitation of a 4′-acylated nucleotide at the 3′-end of a duplex oligonucleotide 
oxidizes low-potential guanine bases at a distance and corroborates the shallow distance 
dependence observed in experiments measuring guanine damage.[40] Theoretical modeling, 
in conjunction with photooxidation of DNA hairpins bridged with a stilbene-
derivative, [83–85] also demonstrate that DNA CT occurs at a distance and these results also 
could not be explained exclusively by a coherent superexchange mechanism.[33] 
Photoexcited anthraquinone, (Figure 3), tethered to one end of a duplex DNA substrate, can 
also be used to damage guanine bases in an oligonucleotide sequence.[36,38,39,46] Schuster 
and coworkers employed this platform, along with computational modeling of DNA 
interactions with Na+ counterions and water molecules in solution, providing results 
consistent with environment-dependent partial charge delocalization on DNA.[39]
After observing rapid, long-distance, and mismatch-sensitive DNA CT in the excited state, 
methods to study DNA CT in the ground state were also developed. Our laboratory has 
utilized both a single-molecule[79,80] and a multiplexed electrode[76–78] platform to study 
ground-state DNA CT. In the single-molecule platform, a gap is first chemically etched into 
a single-walled carbon nanotube (SWCNT). A molecule of single-stranded DNA (ssDNA) 
modified with an amine group at both ends, is covalently attached through amide coupling to 
the oxidatively etched SWCNT, functionalized at the ends with a carboxylic acid group.[79] 
A well-matched complementary strand, or a strand containing a single-base mismatch, is 
then annealed to the ssDNA bridging the etched nanotube. This assembly creates a circuit 
(Figure 4) that allows for measuring the conductance of a single DNA molecule relative to 
the nanotube. The source-drain current measured using this platform demonstrates that 
charge flows through well-matched, but not mismatched, DNA duplexes. Site-specific 
restriction enzyme[79] and methyltransferase activity[80] have moreover been demonstrated 
on duplex DNA substrates in this setup; the DNA circuit is biologically accessible.
Additional single-molecule platforms to study ground-state DNA CT, based on readout from 
electrochemical atomic force microscopy (AFM) or scanning tunneling microscopy 
(STM),[47,48,71] have been designed and used to measure conductance through an 
oligonucleotide. Tao and coworkers[71] measured passage of current at different applied 
voltages through a single 8-bp dsDNA substrate. The DNA is modified at both ends with 
alkanethiol groups, with one end covalently attached to an Au surface and the other end free 
to link covalently to a gold STM tip brought into close contact with the DNA-modified gold 
surface. This study demonstrated consistently high conductance of duplex DNA and a 
shallow distance dependence for DNA CT, relative to electron transfer through σ-bonded 
species.
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Electrochemical AFM studies of conductance through a single DNA molecule have also 
been performed by Porath and coworkers,[47,48] using the platform design in Figure 4. A 
single strand of DNA (26 nucleotide length) is attached to a gold surface through an 
alkanethiol moiety. This strand is hybridized to a complementary strand, which is covalently 
attached to a gold nanoparticle through an alkanethiol moiety. An electrochemical AFM tip 
can then contact the gold nanoparticle on the end of the duplex DNA substrate and measure 
conductance through the oligonucleotide. This platform demonstrated high conductance 
through 26 base pairs of DNA,[47] consistent with other single molecule studies.[71,79,80] It 
was additionally used to demonstrate that duplex DNA, but not single-stranded DNA, is able 
to conduct charge.[48]
The SWCNT circuit, STM, and electrochemical AFM platforms for studying ground-state 
DNA CT through a single molecule are complemented by studies using the multiplexed 
DNA-modified gold electrode platform.[76–78] (Figure 4) This high-throughput system 
facilitates obtaining reproducible electrochemical readouts for ground-state, aqueous DNA 
CT under different conditions (well-matched versus mismatched duplex DNA, for example), 
all on a single electrode surface. DNA-modified gold surfaces are first constructed by 
incubating a duplex DNA substrate with an alkanethiol moiety at one end on the Au(1,1,1) 
surface, allowing a covalent thiol-gold attachment to form. The DNA molecules then form a 
densely packed self-assembled monolayer on gold, oriented at a 45° angle relative to the 
electrode surface, as shown using AFM.[86] After the gold surfaces are incubated with 
alkanethiol-modified DNA and any remaining bare gold is passivated using β-
mercaptohexanol,[76–78] the DNA-modified surfaces become the working electrode in a 
three-electrode cell setup, with a silver/silver chloride reference and a platinum auxiliary 
electrode. Electrochemical techniques such as cyclic voltammetry (CV), square wave 
voltammetry scanning, and bulk electrolysis can be used to monitor the DNA-mediated 
passing of charge between the gold surface and a redox-active species at the distal end of the 
DNA duplex, over a physiologically relevant range of potentials.[24,50,51,72–78,82,86–94]
The multiplexed electrode system (Figure 4) was adapted from a single-surface DNA-
modified electrode platform developed in our laboratory[24,87] and allows for scanning of 16 
DNA-modified electrodes on a single surface. The gold electrodes, each with an area of 
2mm2, are arranged in four quadrants on the silicon chip.[76] These quadrants are divided 
physically from one another in the multiplex chip setup for electrochemistry, so that as many 
as four different DNA substrates can be incubated on one chip. In this manner, facile, 
reproducible readouts for a new experimental condition can be obtained alongside control 
experiments; there is no longer a need to measure two conditions for the same experiment on 
different gold surfaces.
Using our DNA-modified electrode platform, we have observed properties of DNA CT 
consistent with the results of photophysical and single-molecule studies, obtaining readouts 
from both redox-active dyes such as Nile Blue[51,77,94] and DNA-bound enzymes with 
redox-active [4Fe4S] clusters (vide infra).[72–75,78,88,89,92] DNA-mediated redox signals on 
the gold electrode are contingent upon coupling of the redox-active species to the π-stacked 
bases.[23,91] DNA CT additionally has been observed over long distances on this platform; a 
DNA-mediated signal for the redox probe Nile Blue was observed over 100 bp (34nm) of 
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DNA. The signal through 100 bp of duplex DNA remarkably displays the same kinetics and 
mismatch sensitivity as a redox signal through 17 bp of DNA. The distance dependence of 
DNA CT in the ground state is shallow; the rate-determining step is electron tunneling 
through the alkanethiol linker.[77] Finally, DNA CT has been shown to be sensitive to 
perturbations in the base-stacking interactions using this platform; DNA-mediated 
electrochemical signals are attenuated in the presence of base pair mismatches,[23,76,77,95] 
bulky lesions,[50] and structural distortions such as bending of the upright helix through 
binding of TATA-binding protein.[51,52]
The duplex DNA substrates on the multiplex electrode surfaces, importantly, are present in a 
biologically accessible conformation. We have demonstrated, for example, that when a 
binding site for restriction enzyme RsaI is engineered into the 100-bp DNA substrate on the 
multiplex chip platform, RsaI will bind the DNA and cut at the restriction site when 
incubated on the Au electrode.[77] We have additionally demonstrated methyltransferase 
activity on these electrodes, in a setup with a signal-on detection based on the readout from a 
Nile Blue signal.[94] These enzymatic activity readouts were based on redox probe signals, 
but we have also been able to monitor the DNA-bound electron transfer activity of enzymes 
with [4Fe4S] clusters using these electrodes. Incubation of [4Fe4S] repair helicases 
SaXPD[92] and DinG[73] (E. coli) on DNA-modified gold electrodes produces a large, ATP-
dependent DNA-mediated redox signal, associated with the coupling of the [4Fe4S] cofactor 
to the duplex DNA; interestingly, coupling increases with ATP-dependent helicase activity.
Many research groups have thus developed systems which have allowed for characterization 
of the electronic properties of DNA along with effective methods to test how DNA charge 
transport may be used in biology. This long-range, rapid chemistry is sensitive to 
perturbations in the base-stacking interactions, and these characteristics have consistently 
and reproducibly been seen in the ground state and the excited state, on single-molecule, 
ensemble, and multiplexed platforms. Building on the foundation of these robust in vitro 
methods, we can therefore investigate the DNA-mediated charge transfer properties of 
biological systems and how this chemistry is utilized within the cell.
5. DNA Charge Transport in Biology: Initial Observations
After characterizing the fundamental properties of DNA charge transport on a molecular 
level using chemical and physical methods, we next focused on answering the question: can 
DNA CT operate in a cellular environment, modulating reactions at a distance as it does in 
vitro? The first important question to answer was whether DNA CT occurred in cell 
nuclei,[96] where genomic DNA is produced and stored. Upon treatment of HeLa cell nuclei 
with the DNA-intercalating photooxidant [Rh(phi)2DMB]3+ (DMB = 4,4′-dimethyl-2,2′-
bipyridine), we observed long-range oxidation of guanine bases at the 5′-positions in 5′-
GG-3′ doublet and 5′-GGG-3′ triplet sequences upon irradiation of the samples to 
photoexcite the Rh(III) compound. Damage at 5′-guanines in 5′-GGG-3′ and 5′-GG-3′ 
sites, a signature of DNA-mediated one electron oxidation, was furthermore demonstrated in 
mitochondria, [97] upon irradiation of a Rh(III) intercalating photooxidant. Long-range 
oxidation of low-potential guanine sites occurred in cells, affecting regions to which proteins 
were known to bind and those free of proteins; [96] for example the binding of a transcription 
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factor[96] did not inhibit DNA-mediated damage of guanine residues; charge can migrate 
through bases as long as the helical structure and stacking interactions are not distorted.
We also investigated whether DNA CT could occur through duplex DNA bound in a 
nucleosome core particle (NCP), the fundamental unit of DNA packing in eukaryotic cells. 
(Figure 5) An octameric complex of histone proteins binds and wraps ~150 bp of duplex 
DNA in an NCP structure, which then is further assembled into higher-order structures in the 
nucleus. [98,99] Since a large portion of the eukaryotic genome is bound in these structures, 
which curves the helix gently around the histone core, it is relevant to ask whether CT can 
occur through histone-bound DNA to affect genome-wide reactions. Using the DNA-
intercalating [Rh(phi)2(bpy)]3+ photooxidant tethered to DNA in the presence and absence 
of histones, we observed long-range oxidative damage to 5′-guanine bases in 5′-GG-3′ 
doublets and 5′-GGG-3′ triplets.[100] As DNA CT occurs in histone-bound, packaged DNA, 
it is a feasible mechanism for genome-wide signaling and sensing of oxidative stress 
conditions in eukaryotic cells. This result also confirms further that DNA CT can occur 
through protein-bound DNA as observed in HeLa cell nuclei, as long as the π-stacking base 
interactions are maintained.
Protein binding which does perturb the coupling of the π-stacked bases, however, can 
modulate charge transfer through DNA. TATA-binding protein (TBP), for example, is a 
ubiquitous transcription factor that bends DNA approximately 80° when it binds.[101] We 
have demonstrated using our DNA electrochemistry platform that TBP attenuates DNA CT 
in binding and severely kinking the double helix, disrupting base pair π-stacking 
interactions.[51] TBP binding and kinking of the DNA double helix therefore allows for 
modulation of redox reactions at a distance by changing the CT properties of protein-bound 
DNA. This modulation is reversible, occurring only when TBP is bound to a segment of 
duplex DNA. It is dependent on the structural properties of the DNA helix in the presence or 
absence of a binding event and suggests that proteins, in modulating DNA CT, can play a 
range of regulatory roles during the cell cycle.
One important dynamic condition in the cellular environment which requires a biological 
response is oxidative stress.[102] SoxR is a transcription factor in enteric bacteria containing 
a [2Fe2S] cluster and is responsible for binding the soxS promoter in the bacterial genome to 
activate transcription of genes to respond to oxidative stress in the cell.[102,103] SoxR binds 
DNA as a dimer, and the apo-form, which does not contain the cluster, binds with a similar 
affinity as the holoenzyme containing the [2Fe2S] cofactor.[104] The transcriptional 
activation activity, however, is dependent on the cluster.[105] We showed using DNA 
electrochemistry that SoxR undergoes a potential shift of +490mV when bound to DNA, 
suggesting that the DNA-bound protein is generally in the reduced [2Fe2S]+ state but can be 
oxidized to the [2Fe2S]2+ state at cellular potentials where oxidative stress arises.[52] SoxR 
is capable of DNA-mediated redox activity when bound to DNA, but can this transcription 
factor respond to oxidative stress at a distance in a DNA-mediated manner?
To investigate whether DNA charge transport can modulate the redox state, and therefore the 
transcriptional activity, of SoxR at a distance, we employed DNA-intercalating 
photooxidants. We demonstrated with noncovalently bound [Ru(phen)(dppz)(bpy′) ]2+ 
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(dppz = dipyridophenazine, bpy′= 4-butyric acid 4′-methyl bipyridine), that reduced 
[2Fe2S]+ SoxR can become oxidized to fill guanine radicals created by the Ru(II) oxidant 
upon irradiation. We then examined directly whether this oxidation of SoxR could be 
mediated by DNA.[106] Using a DNA-intercalating [Rh(phi)2(bpy′)]3+ photooxidant tethered 
to one end of a 180-nt duplex DNA substrate, which contained the SoxR binding sequence 
in the soxS promoter 80-nt from the site of intercalation, we were able to observe not only 
oxidation and but also activation of bound, transcriptionally silent [2Fe2S]+ SoxR through 
DNA. (Figure 5) The irradiated [Rh(phi)2(bpy′)]3+ promotes transcriptional activity 
associated with oxidized [2Fe2S]2+ SoxR in vitro through 80 bp of well-stacked DNA.[106] 
DNA CT thus provides a mechanism for activation of SoxR at long range during oxidative 
stress.
Recent studies of the bacterial miniferritin Dps also suggest that DNA CT can be used by 
many different proteins in order to preserve genomic integrity. Dps is associated with the 
virulence of pathogenic bacteria and their ability to tolerate oxidative stress.[107] This 
protein can bind DNA nonspecifically and employs ferroxidase chemistry to deplete the 
surroundings of Fenton reagents such as Fe2+ and H2O2.[108] We demonstrated that Dps is 
capable of neutralizing guanine radicals through DNA CT using flash-quench 
techniques.[109] A [Ru(phen)(dppz)(bpy′)]2+ (bpy′= 4-butyric acid-4′-methyl-2,2′-
bipyridine) complex which intercalates into duplex DNA was tethered to one end of a 70-nt 
DNA substrate. Upon irradiation, this oxidant creates guanine radicals at the 5′-G of a 5′-
GGG-3′ triplet site engineered into the DNA sequence. DNA-bound ferrous iron-loaded 
Dps, but not apo-Dps or ferric iron-loaded Dps, reduced the oxidized guanine radical from a 
distance through DNA CT. (Figure 5) Long-range redox chemistry can thus be employed by 
many different proteins with a diverse array of structural and functional properties, if these 
proteins can bind duplex DNA and effectively couple into the π-stacked bases.
6. DNA Charge Transport Signaling By Base Excision Repair Glycosylases 
coordinating a [4Fe4S] Cluster
As the evidence grew that DNA CT could be exploited for rapid and long-range redox 
sensing and signaling, exploring how DNA CT could be involved in other cellular processes 
essential for genome stability became increasingly important.[110] As discussed above, our 
attention turned to an emerging class of nucleic acid processing enzymes that coordinate 
[4Fe4S] clusters.[62] For most repair enzymes discovered to date, the biochemistry of the 
pathways and the implications for the etiology of disease states have already been 
exquisitely characterized, and many exhaustive reviews are available.[111–132] The 
biochemical role of the [4Fe4S] cluster in DNA repair enzymes, however, remained unclear 
for a long time after the cofactor was demonstrated to be present. Though the [4Fe4S] 
cluster is a well known and versatile metallocenter found in all domains of life that serves as 
a redox cofactor in many major biochemical systems,[64] it was first hypothesized that the 
cluster primarily has a structural role in DNA-binding repair enzymes.[62] Many of these 
proteins, however, do not require the cluster for stability or protein folding.[55,133] There is 
evidence that a stable and intact cluster is necessary for substrate recognition and turnover 
but not for a role in catalysis, suggesting a regulatory role for the cluster in enzymatic 
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function.[55,133,134] One might furthermore expect, given the possibility of Fenton chemistry 
with the iron-sulfur clusters near DNA, that a more redox-inert structural motif would better 
stabilize DNA binding.[64]
The first proteins containing [4Fe4S] clusters studied from the perspective of DNA CT were 
from the base excision repair (BER) pathway. Some BER substrates include, for example, 
apurinic/apyrimidinic sites, 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxo-G):A mismatches, 
alkylated or oxidized bases, and uracil that has been incorrectly incorporated into the 
genome.[112] In 1989, Endonuclease III (EndoIII), an N-glycosylase and AP-lyase from E. 
coli that senses damaged pyrimidines, was the first DNA repair enzyme containing a 
[4Fe4S] cluster to be discovered. EndoIII coordinates the cluster in a Cys-X4-Pro-X-Cys-
X2-Cys-X5-Cys loop located near the C terminal domain (CTD).[53] The cluster is strongly 
conserved in all domains of life. The presence of the cluster was initially a surprise, but the 
discovery of the cluster in EndoIII was quickly followed by prediction and demonstration of 
a cluster in a homologous E. coli enzyme, MutY, a glycosylase which resolves 8-oxo-G:A 
lesions, and like EndoIII, is strongly conserved in prokarya, eukarya, and archaea.[135–137] 
The third BER enzyme, family 4 Uracil-DNA glycosylase from the thermophilic bacterium 
Archeoglobus fulgidus, (AfUDG), was additionally found to coordinate a [4Fe4S] 
cluster.[56] Thermophilic family 4 UDGs are the only known UDGs to contain a [4Fe4S] 
metallocenter; in most bacteria UDG does not contain a cluster but is in very high 
concentrations in the cell (in contrast to the BER enzymes with clusters). It is also 
interesting that cytosine deamination, which generates uracils within DNA, is 
overwhelmingly favored at the higher temperatures of thermophiles.
Structural characterization of the BER glycosylases has been instrumental in efforts to 
understand why a metabolically expensive and potentially reactive [4Fe4S] metallocenter 
would be found in enzymes that interact directly with DNA.[54,138–140] First, structures for 
EndoIII, MutY, and UDG from Thermus thermophilus (TfUDG, homologous to AfUDG) 
consistently show that the cluster is located remotely from the enzymatic active site, where a 
base is flipped out and excised; it is therefore unlikely that the cluster is directly involved in 
active site catalysis (Figure 6) [119]. The DNA-free and DNA-bound structures of EndoIII 
and MutY are moreover remarkably similar, so a large conformational change is not 
associated with DNA binding. Secondly, in DNA-bound crystal structures of EndoIII and 
MutY, the cluster is consistently located roughly 15–20 Å away from the double helix with a 
pathway of aromatic amino acids sandwiched between the cluster and the DNA 
substrate.[74,88,89] Given the pioneering work by the Gray group on protein electron transfer 
pathways,[141–147] the aromatic residues are highly suggestive of an electron transfer 
pathway from the DNA to the cluster. Hence, given these characteristics of the clusters in the 
repair enzymes, we were prompted to begin determining if the [4Fe4S] clusters coordinated 
by DNA repair proteins were redox active and could participate in DNA CT chemistry.
Initial efforts by others to study the redox chemistry of the [4Fe4S] cluster in EndoIII were 
met with several challenges. The cluster was purified in the [4Fe4S]2+ oxidation state 
(formally two ferric and two ferrous irons), and the cluster oxidation states were difficult to 
access with redox mediators.[53] The [4Fe4S]2+ degraded to the [3Fe-4S]1+ species in the 
presence of ferricyanide, and the [4Fe4S]1+ species could only be isolated by anaerobic 
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photoexcitation which generated powerful radical reductants in situ resulting in an estimated 
reduction potential of < −600 mV vs. NHE.[53] These initial attempts to oxidize and reduce 
the EndoIII cluster were, however, carried out in the absence of DNA, a polyanion that 
would surely affect DNA-bound redox potentials. Our approach was to adapt the DNA-
modified gold electrode platform for protein electrochemistry, using EndoIII, MutY, and 
AfUDG rather than small molecules as the redox probes.[88,89] Interestingly, reversible 
redox activity for all three glysosylases in the presence of DNA was seen by cyclic 
voltammetry (CV), with positive, midpoint potentials between 60 and 100 mV vs. NHE, 
which is characteristic of high iron potential [4Fe4S] proteins (HiPIPs) (Figure 7).[148] 
Critically, there was not any observed degradation of the cluster under these conditions. 
Redox activity could not be observed in the absence of DNA or was greatly attenuated in the 
presence of an abasic site. Though abasic sites are not direct substrates of EndoIII, MutY, or 
UDG, the redox sensing of this DNA lesion by the BER glycosylases was an exciting 
discovery, and together, these data indicated that the redox activity of the [4Fe4S] cluster 
was facilitated and mediated by DNA (Figure 7).
The newly discovered [4Fe4S] redox activity on DNA highlighted several key features of 
this unrealized mode of biological electron transfer. While there is not a marked 
conformational change associated with DNA binding, protein binding to DNA appears to 
have a dramatic effect on the potential of the [4Fe4S]3+/2+ couple. The [4Fe4S]2+ resting 
state of the HiPIP glycosylases appeared to be activated toward oxidation within a potential 
range that is biologically accessible and does not damage the DNA bases, even within 
guanine repeat sequences.[149,150] On a graphite electrode, where DNA-bound and 
dissociated forms can be compared directly, the shift in potential was found to be ~100 mV 
negative on DNA binding.[151] The oxidation state of [4Fe4S] clusters is known to vary 
widely depending on the local environment,[148, 152] and the shift in potential with the BER 
glycosylases is readily explained by the change from a solvent-exposed cluster in the DNA-
free state to the more negatively-charged local environment in the DNA-bound state.[89] 
Certainly the application of [4Fe4S] clusters in these enzymes offered an opportunity to tune 
the potential of the cluster to a redox-active form at cellular potentials when bound to DNA.
7. DNA CT Signaling Activity by DNA Helicases with [4Fe4S] Clusters
Concurrent to the initial characterization of the BER glycosylases, a burst of proteins 
involved in genome maintenance from repair, replication, recombination, and transcription 
were reported to coordinate a [4Fe4S] cluster.[30,31,66] Very quickly, there was ample 
opportunity to study the redox chemistry of many other [4Fe4S] enzymes in repair pathways 
other than BER. We initially focused, as introduced above, on two ATP-dependent, 5′-3′ 
Superfamily 2 Helicases, XPD and DinG. XPD is an essential component of the 
transcription factor IIH (TFIIH) machinery that unwinds DNA during nucleotide excision 
repair (NER) and transcription in archaea and eukarya.[131] Mutations in the XPD gene are 
associated with trichothiodystrophy, Cockayne syndrome, and Xeroderma pigmentosum. As 
with the BER glycosylases, many mutations in XPD associated with genetic diseases are 
known, but how some of these mutations lead to disease remained poorly understood.[75,92] 
Interestingly, evidence now points to an association between cluster destabilization and 
disease development. The second helicase we examined, DinG, is an E. coli SOS-inducible 
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protein that shares some sequence homology with XPD, most strongly in the [4Fe4S] cluster 
domain.[58,153] DinG is responsible for resolving R-loops (DNA:RNA duplexes) and is 
required for maturation of R-loops at stalled replication forks.
When SaXPD from the archaea and DinG from E. coli were studied electrochemically on 
the DNA-modified gold electrode platform, both helicases were found to participate in DNA 
CT chemistry.[73,92] Furthermore, they shared the same DNA-bound redox potential as the 
BER glycosylases, approximately 80mV vs. NHE.[73,92] Consistent with the previous 
studies of BER [4Fe4S] enzymes, the signal was attenuated, but not shifted, in the presence 
of an intervening lesion (a mismatch in these studies, also not a substrate for the enzymes). 
Further probing of the CT activity found that in the presence of ATP, the signal for SaXPD 
and DinG quite stunningly increased in a concentration-dependent manner without any shift 
in the midpoint potential. Hence, it appears that helicase activity increases the 
electrochemical signal and coupling of the cluster to the π-stacked DNA bases, signaling 
electrochemically that the helicase is active. This electrical detection of redox-independent 
enzymatic activity by the helicases on DNA substrates is thus yet another intriguing 
indication of a redox role for the [4Fe4S] cluster and DNA CT in DNA biology. Indeed, two 
mutants of SaXPD, G34R and L325V (L461 in human XPD), associated with disease, were 
both found to be CT-deficient, but enzymatically active.[75,92] Additional studies will be 
instructive in how CT signaling of enzymatic activity might be utilized in vivo.
8. A Model for Lesion Detection Using DNA CT
With the discovery of the DNA CT redox activity of the [4Fe4S] cluster and that redox 
activity depends upon DNA binding, we sought to explore roles for this chemistry within the 
cell. One essential protein function CT deficiency could impair is the ability to detect and 
localize to damaged bases. Repair proteins are challenged with the enormous task of 
discriminating the billions of unmodified bases from the thousands of damage sites 
generated per day, many of which are structurally very similar to their undamaged 
counterparts.[110] The protein traffic on DNA in the form of transcription factors, other 
repair proteins, RNA polymerases, DNA polymerases, and histones (in eukaryotes) adds 
layers of complexity to the processes that must be coordinated in order to maintain genomic 
integrity. Furthermore, in E. coli the copy numbers of MutY and EndoIII per cell are 
limiting: MutY is expressed at ~30 copies/cell and EndoIII is expressed at ~500 copies/
cell.[30,31] Indeed, a basic model of genome scanning that includes facilitated diffusion 
constants for the E. coli genome (4.6 × 106 base pairs) and a protein copy number of 30 
under the assumption of instantaneous lesion detection and no protein traffic predicts a 
search time of 46 minutes to find a single lesion, far too long for an organism with an 
average doubling time of 20–30 min.[72] Hence other factors must facilitate efficient lesion 
detection.
Detection of damaged lesions through DNA CT, which is exquisitely sensitive to 
perturbations to the base stack (even to lesions that do not distort the helix) and an excellent 
reporter of base stack integrity, is one such mechanism that could enhance the DNA damage 
search efficiency. This mechanism may be especially relevant for proteins expressed at low 
copy numbers. Utilization of DNA CT in the cell for more efficient lesion detection could 
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explain why many DNA repair enzymes coordinate a redox-active [4Fe4S] cofactor. As 
such, a new model for DNA-mediated sensing and signaling as a first step in lesion detection 
was proposed based on the DNA-bound redox behavior and the shared midpoint potential of 
the [4Fe4S] repair enzymes (Figure 8).[30,31,72,89]
In this model, iterative signaling across the genome involves redox communication between 
a protein donor in the [4Fe4S]2+ state (the resting state for HiPIP proteins, and favored in the 
reducing cellular environment) and a distally-bound acceptor, already in the [4Fe4S]3+ state. 
We have seen that guanine radicals, presumably generated under oxidative stress, can 
oxidize the clusters of DNA-bound repair proteins, generating the [4Fe4S]3+ state.[89] Upon 
binding to DNA, the donor is activated toward oxidation and can reduce the distally bound 
acceptor protein in a self-exchange electron transfer reaction if the intervening DNA is free 
of lesions. The acceptor, now in the [4Fe4S]2+ state, can more easily diffuse away to another 
region of the genome due to the decreased binding affinity of the protein for DNA once in 
the reduced state. This iterative process can repeat to facilitate communication between 
[4Fe4S] proteins in the same repair pathway or in different repair pathways. If, however, 
there is a lesion between the donor and acceptor pair, redox signaling is disrupted and the 
lesion is sensed by the cluster proteins on either side of the lesion. The [4Fe4S] proteins 
bound on either side of the lesion become “trapped” on the DNA in the [4Fe4S]3+ state, and 
the proteins that are “trapped” on the damaged DNA strand can then move processively on 
the double helix to localize to the precise location of the lesion. Proteins “trapped” on 
damaged strands can also recruit other protein complexes necessary for timely repair. 
Including a CT search component in the model of genome scanning with CT distances of 
only a few hundred bases predicts that a protein with a copy number as low as 10 can scan 
the genome for lesions in 6 minutes, which is within reason for E. coli.[72]
9. Cooperative, Redox Signaling Between [4Fe4S] Proteins
A key component of the proposed CT scanning model is the localization of CT-proficient, 
[4Fe4S] cluster proteins in the vicinity of damage, after scanning undamaged regions of the 
genome. A way to visualize how [4Fe4S] proteins distribute onto damaged versus 
undamaged DNA was developed using AFM.[72] For the AFM redistribution assay, two sets 
of DNA substrates, one which includes long, well-matched (WM), 3.8 kb duplex DNA and 
one which includes long, mismatched (MM) DNA (3.8 kb) engineered to contain a single 
C:A mismatch but is otherwise identical to the WM strand, are prepared. Both WM and MM 
DNA samples also include shorter strands (1.6 and 2.2 kbp) of undamaged DNA. EndoIII, 
SaXPD, and DinG were all studied as uniform samples and in mixtures with other [4Fe4S] 
repair proteins using the AFM redistribution assay. An increased density of protein was 
consistently found on long, MM DNA relative to the shorter, undamaged DNA 
substrates.[72–75] Remarkably, comparable binding density ratios of approximately 1.5 (MM/
short, undamaged, see Figure 9) were observed for all CT-proficient repair proteins studied 
thus far, even though C:A mismatches are not native substrates for any of the enzymes 
studied. In stark contrast to the WT [4Fe4S] proteins, all the CT-deficient mutants visualized 
by AFM, EndoII Y82A, EndoIII Y75A, and SaXPD L325A, were found to have a binding 
density ratio of 1, showing no preference for the long, MM strand. Indeed, a direct 
correlation was found between the electrochemical signal of a given protein cluster on the 
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DNA-modified electrode, a measure of DNA CT ability, and the binding density ratio seen 
in the redistribution assay, a measure of the ability of the repair protein to find the 
mismatched strand.[74] Moreover, mixtures of wild type protein and CT-deficient mutants, 
for example EndoIII:Y82A and wild type EndoIII, or XPD mixed with XPD:L325V, also 
were found to have a binding density ratio of 1, consistent with the idea that CT-deficient 
mutants cannot participate in signaling to another protein.[72,75]
We have additionally used the AFM redistribution assay to monitor communication between 
signaling partners from distinct repair pathways.[73] Binding density ratios of samples 
containing mixtures of BER glycosylase EndoIII and R-loop repair helicase DinG were 
found to be comparable to binding density ratios found for samples containing only EndoIII, 
DinG, or XPD (Figure 9). Consistent with these findings, protein mixtures containing DinG 
and CT-deficient Y82A (Figure 9), did not show a preference for damaged DNA. In fact, 
AFM studies with signaling partners from different organisms, EndoIII (E. coli) and XPD 
(S. acidocaldarius), showed a higher density of proteins on the mismatched strands of DNA, 
again with a binding density ratio of 1.5, just as were found for mixtures of proteins from the 
same organism.[75] Furthermore, no preference for damaged DNA was seen in protein 
mixtures containing XPD: EndoIII Y82A, EndoII: XPD L325V, and EndoIII Y82A: XPD 
L325V. These findings were remarkable, and suggested to us that signaling between [4Fe4S] 
cluster proteins is not dependent on the type of protein (endonuclease, glycosylase, or 
helicase) or even on the native organism. What forms the basis for the long range signaling 
is the ability of these proteins to bind DNA and couple their clusters electronically to the π-
stacked bases in the DNA duplex. Thus these results are fully consistent with a model of 
lesion detection through long-range, DNA-mediated redox signaling between [4Fe4S] repair 
proteins. CT-deficient mutants that cannot fully participate in DNA CT chemistry are unable 
to sense the lesions electrochemically, which impairs the search efficiency (redistribution 
onto damaged strands).
After observing robust and consistent evidence for DNA-mediated redox signaling in vitro, 
we next turned to genetics assays to probe for DNA-mediated signaling in vivo. The general 
strategy of the in vivo assay is to select a strain of E. coli that relies on the repair protein for 
its survival, then genetically knockout a putative signaling partner containing the [4Fe4S] 
cluster, and monitor how the absence of the signaling partner affects activity/survival (Figure 
10). If DNA-mediated CT is used to scan the genome for lesions, then decreasing the 
number of signaling partners in the cell should have a measurable effect on growth. Any 
growth defects should also be reversible, and to pinpoint the basis for rescue, 
complementation plasmids are introduced into the knockout strains to express either the wild 
type signaling partner or mutants that are CT-deficient and enzymatically active or redox-
active but enzymatically inactive.
The first in vivo assay we developed reports on the repair activity of MutY in the CC104 
strain of E. coli.[72] The CC104 strain contains a cytosine rather than an adenine in the lacZ 
gene at the Glu-461 codon which is essential for metabolizing lactose (Figure 10).[154] 
When MutY activity is impeded, an increase in GC-to-TA transversions occurs, restoring the 
lacZ gene and growth (revertants) on minimal media where the only carbon source is 
lactose. When EndoIII or DinG genes (nth and dinG, respectively) are knocked out of the 
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CC104 strain, a significant, but not dramatic (roughly two-fold) increase in revertants is 
observed (Figure 10).[72] To test if the wild type phenotype could be restored, 
complementation plasmids were introduced expressing either Y82A, the CT-deficient but 
catalytically active EndoIII mutant, or D138A, which is a catalytically inactive but CT-
proficient mutant of EndoIII. Consistent with our CT scanning model, the Y82A plasmid 
could not restore the wild type phenotype, but the D138A plasmid could restore the wild 
type phenotype for both EndoIII and DinG knockout strains. Thus, the ability of MutY to 
find lesions relies on redox signaling with EndoIII[72] and DinG[73] to find lesions, and 
moreover, the enzymatic functions of EndoIII and DinG do not appear to be relevant to this 
process.
To probe the signaling network further, another, more sensitive in vivo assay was developed 
that reports on the repair activity of DinG in the Inverted A (InvA) strain of E. coli.[155] In 
the InvA strain, the highly-transcribed rrnA operon in inverted, which increases the 
frequency of collisions between transcription and replication machinery and the formation of 
R-loops (Figure 10). DinG is required for resolving these types of lesions, and so, to test if 
DNA-mediated CT signaling is needed for DinG repair activity, the EndoIII gene was 
knocked out in the InvA strain, and growth rescue was attempted with plasmids expressing 
Y82A or D138A. The growth of the InvA Δnth mutant strain is severely compromised, but, 
growth can be completely rescued with the D138A plasmid, whereas the Y82A plasmid did 
not have a measurable effect on growth (Figure 10).[72] Like MutY, DinG also appears to 
rely on DNA CT chemistry to repair lesions. The ability of a catalytically inactive EndoIII 
enzyme (D138A) to rescue growth to wild type levels appears to be achieved simply through 
the increase of cellular concentration of redox-active [4Fe4S] protein to help in scanning the 
genome. Results from genetics assays reporting on both MutY[72,73] and DinG[73] activity 
thus highlight the power of DNA CT that is only now beginning to be realized in DNA and 
RNA biological processes. As other DNA-processing proteins containing [4Fe4S] clusters 
are discovered, we will be able to continue testing how DNA CT may be used in redox 
signaling networks.
10. Summary and Outlook
Charge transport through the π-stacked bases at the center of the DNA helix occurs over 
long range and in a rapid manner gated by the dynamic motion of DNA bases in solution. 
DNA-mediated charge transport is moreover dependent on the coupling of electron donors 
and acceptors to the base stack, and on the stacking interactions between the π orbitals of 
the nitrogenous bases. Base-pair mismatches, bulky oxidative lesions, and severe bending of 
the helix all attenuate DNA CT; this property is exquisitely sensitive to structural 
perturbations affecting π-stacking. These fundamental characteristics of DNA charge 
transport are utilized by DNA-binding redox active proteins both to sense oxidative damage 
at a distance and participate in long-range protein-protein redox signaling. Using a variety of 
platforms including biochemical and genetic studies, we have observed that DNA-binding 
enzymes containing [4Fe4S] clusters are capable of signaling one another through well-
matched duplex DNA. Repair enzymes redistribute in the vicinity of oxidative lesions as a 
result of DNA-bound redox activity, where DNA CT appears to be harnessed by the cell as a 
first step in locating damaged DNA for repair.
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As enzymes central to DNA-processing pathways, including eukaryotic DNA 
replication,[60,156] have also been discovered to contain essential [4Fe4S] cofactors, it 
remains now to uncover the functional role of these clusters in DNA processing. Does long-
range electron transfer between DNA polymerases containing [4Fe4S] clusters play a part in 
coordinating the dynamic and complex process of genome duplication? What other enzymes 
in DNA-processing pathways contain a [4Fe4S] cluster? Continued work is necessary and 
important for illuminating how Nature uses the elegant and powerful chemistry of DNA 
charge transport in biological systems.
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Figure 1. 
The structure of DNA shows chemical similarities to graphene sheets. A) Schematic of the 
DNA helix. The aromatic bases at the center of the DNA helix are oriented so that the π 
orbitals of adjacent bases overlap with one another in the duplex DNA structure. B) Looking 
down the helix axis showing aromatic base pairs (light blue) stacked in 3.4Å layers at the 
center of DNA. C) Structure of graphite.
O’Brien et al. Page 22
Isr J Chem. Author manuscript; available in PMC 2017 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Iron-sulfur clusters in biology. A) Structures of common iron-sulfur cofactors, the rhomboid 
[2Fe2S] cluster, the [3Fe4S] cluster, and the cubane [4Fe4S] cluster. B) Eukaryotic (above) 
and bacterial (below) iron-sulfur cofactor assembly and incorporation into proteins. C). 
Fenton chemistry.
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Figure 3. 
Platforms to study DNA CT in the excited state. A) A covalently tethered DNA-assembly to 
probe long range emission quenching through DNA CT B) An assembly to monitor DNA-
mediated oxidation of low-potential guanine bases by a tethered rhodium photooxidant[26] 
C) An assembly to monitor long range oxidative damage with a DNA-capped 
anthraquinone.[37,39]
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Figure 4. 
Platforms to study DNA CT in the ground state. A) Single-molecule carbon nanotube 
device[79,80] measuring the source-drain current ISD at a constant applied voltage. 
Significant current flow is apparent with the well matched duplex (top) but not with an an 
intervening mismatch (below) B) Electrochemical atomic force microscopy is used to 
measure current passage through an oligonucleotide duplex attached to an Au surface at one 
end and a Au nanoparticle at the other end.[47,48] C) Multiplexed, DNA-modified Au 
electrodes facilitate robust, reproducible electrochemical scans of DNA monolayers on a Au 
surface.[76–78] Long-range (top) and mismatch-sensitive (bottom) DNA CT to redox probes 
(left) or protein (right) are observed.
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Figure 5. 
DNA CT occurs in various biological assemblies. A) Long range photooxidation through a 
nucleosome core particle. [96] B) Long range activation of SoxR in response to oxidative 
stress.[106] C) Long range protection of oxidative DNA damage by Dps[109]
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Figure 6. 
Structures of Endonuclease III (EndoIII). [138,139] The overlay of the free EndoIII structure 
(E. coli, gray, PDB ID: 2ABK) and the DNA-bound structure (T. thermophilus, light teal, 
PDB ID: 1ORN) shows little change in conformation upon binding to substrate (left). In 
both forms, the [4Fe4S] cluster (orange and yellow spheres) is located remotely (15.2 Å) 
from the active site, (dotted line, right, PDB ID: 1ORP), though the cluster is in close 
proximity to DNA (17.1 Å). The above images were generated in PyMOL.
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Figure 7. 
DNA CT to EndoIII Electrochemically with assemblies (above) and CV’s (below). For WT 
EndoIII (green) a reversible CV is found, that is attenuated with an intervening mismatch 
(grey). For the CT-deficient Y82A mutant (blue) the CV signal is also attenuated.
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Figure 8. 
A Model of DNA-mediated Redox Signaling Between [4Fe4S] DNA Processing Enzymes 
for Enhanced Lesion Detection.[30,31] Freely-diffusing (top left, tan oval) [4Fe4S] protein in 
2+ state (red and yellow cluster) is activated toward oxidation upon binding to DNA (3+ 
state, light and dark purple cluster), and can reduce a distally-bound protein (mauve oval) to 
the 2+ state. In the 2+ state, diffusion to another region of the genome and repeated CT 
scanning to search for lesions (middle strand, mauve and blue ovals) can occur. If there is an 
intervening lesion between two signaling partners (bottom strand, blue and rose ovals), 
redox communication is interrupted (black arrow with red X), resulting in both proteins 
trapped on DNA in the 3+ state which allows for procession toward the lesion (dotted 
arrows) and subsequent repair of the damage.
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Figure 9. 
Visualization of protein localization on mismatched DNA by AFM.[72–75] In the AFM 
redistribution assay (left), [4Fe4S] protein or protein mixtures are incubated with DNA 
substrates which contain either long, WM or MM strands (3.8 kbp), and short, WM DNA 
stands (1.6 and 2.2 kbp) and imaged (middle). The proteins bound to long strands of DNA 
are counted, normalized, and expressed as a binding density ratio (right). Consistently, CT-
proficiency determines if redistribution the mismatched substrate occurs.
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Figure 10. 
Genetic Assays for Detection of DNA CT Signaling Among E. coli [4Fe4S] Repair 
Proteins.[72,73] In the MutY Activity assay (left), impaired MutY activity in the CC104 strain 
leads to an increase in GC to TA transversions at the lacZ gene and to an increase in 
revertants on lactose-only media. In the DinG activity assay (right), impaired activity of 
DinG in the InvA strainleads to a dramatic growth defect. Knocking out EndoIII (Δnth) 
impaired both MutY and DinG activity (dark blue bar, left, and dark blue curve, right). 
Rescue in both assays could be achieved by addition of CT-proficient, but enzymatically-
inactive protein (green bar, left, and green curve, right), but not CT-deficient, though 
enzymatically active Y82A (light blue bar, left, and light blue curve, right).
O’Brien et al. Page 31
Isr J Chem. Author manuscript; available in PMC 2017 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
